Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001487-32Phase 4Active
Phase 4, randomised, double-blind trial in idiopathic sudden sensorineural hearing loss (ISSNHL) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Improvement in pure tone audiogram at 3 months. Started Sep 2005; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001487-32.